Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial
- Resource Type
- Article
- Authors
- Trněný, Marek ; Lamy, Thierry; Walewski, Jan; Belada, David; Mayer, Jiri; Radford, John; Jurczak, Wojciech; Morschhauser, Franck; Alexeeva, Julia; Rule, Simon; Afanasyev, Boris; Kaplanov, Kamil; Thyss, Antoine; Kuzmin, Alexej; Voloshin, Sergey; Kuliczkowski, Kazimierz; Giza, Agnieszka; Milpied, Noel; Stelitano, Caterina; Marks, Reinhard; Trümper, Lorenz; Biyukov, Tsvetan; Patturajan, Meera; Bravo, Marie-Laure Casadebaig; Arcaini, Luca
- Source
- In The Lancet Oncology March 2016 17(3):319-331
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045